NSD1 and head and neck squamous cell carcinoma: NSD1 has been identified as a biomarker for global epigenetic changes in cancer (37, 38) and based on TCGA data, it was recently suggested as a prognostic biomarker in patients with HPV-negative HNSCC (39).